SureTrader SureTrader
Home > Boards > US OTC > Biotechs > Amarantus Bioscience Holdings Inc. (AMBS)

Amarantus BioScience (AMBS) <u>Price Target $2.25 By Fall</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BCNstocks Member Profile
Member Level 
Followed By 335
Posts 37,121
Boards Moderated 0
Alias Born 08/28/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2016 5:03:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/27/2016 5:20:06 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 10/7/2016 5:09:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2016 5:20:16 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 9/9/2016 5:24:57 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/16/2016 6:04:54 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2016 8:15:24 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 8/5/2016 4:26:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/8/2016 4:11:35 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/1/2016 1:52:07 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 6/1/2016 1:22:14 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/16/2016 5:55:11 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 5/16/2016 4:14:23 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/21/2016 4:21:56 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/30/2016 5:40:56 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 3/14/2016 5:30:37 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/7/2016 5:02:44 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/4/2016 5:28:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2016 4:17:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/24/2016 4:15:34 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 2/23/2016 6:08:20 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/18/2016 5:09:41 PM
Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug "InvestorsHub NewsWire" - 2/10/2016 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2016 4:32:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/2/2016 10:36:42 AM
BCNstocks Member Level  Tuesday, 02/26/13 12:36:25 PM
Re: None
Post # of 125667 
Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review:

Amarantus BioScience (AMBS) Price Target $2.25 By Fall 2013 Forecasts Biotech News Stock Review. AMBS has a huge upside, look for this small biotech to take off soon on some very good news that we are hearing. By Fall today's share price will only be a distant memory!


http://biotechnewsstockreview.blogspot.com/2013/01/amarantus-bioscience-ambs-price-target.html



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist